Szabóová Eva, Lisovszki Alexandra, Kolarčik Peter, Fatĺová Eliška, Molnár Tomáš, Bujdoš Martin, Szabó Peter
Department of Angiology, Faculty of Medicine, Pavol Jozef Šafárik University in Košice and East Slovak Institute of Cardiovascular Diseases, 040 11 Košice, Slovakia.
4th Department of Internal Medicine, Faculty of Medicine, Pavol Jozef Šafárik University in Košice and Louis Pasteur University Hospital, 041 90 Košice, Slovakia.
Rev Cardiovasc Med. 2024 Mar 12;25(3):103. doi: 10.31083/j.rcm2503103. eCollection 2024 Mar.
Several markers have been proposed for the detection and progression of subclinical atherosclerosis. We aimed to analyse the impact of classical risk factors on the presence and short-term progression of subclinical carotid atherosclerosis in a non-diabetic, primary prevention cohort.
This analysis included participants with completed visits at baseline and at 5-year follow-up (N = 141; 56.7% females, 43.3% males; aged 49.6 4.7 years). Clinical and laboratory parameters, risk profiles, carotid artery intima-media thickness (CIMT) and plaque presence were analysed.
There was a significant progression in mean CIMT (0.54 0.09 mm-0.62 0.10 mm; 0.001), prevalence of carotid plaque (4.8%-17.9%; 0.001) and age- and sex-adjusted abnormal CIMT (52.9%-78.8%; 0.001) at the end of follow-up, compared to baseline. In multivariate regression analysis, among the classical risk factors, their number, metabolic syndrome and SCORE (Systematic Coronary Risk Estimation) risk only the number of risk factors showed an independent and significant impact on the occurrence of a carotid plaque (Exp(B) = 1.71; = 0.017) and 5-year CIMT progression.
During a short follow-up, the significant progression of subclinical atherosclerosis was confirmed. The number of risk factors predicted the occurrence of carotid plaques and CIMT progression. The high prevalence and short-term progression of subclinical carotid atherosclerosis underly the rationale for its screening in personalized cardiovascular risk stratification in asymptomatic middle-aged subjects over 50 years old, at low-to moderate cardiovascular risk, particularly with several risk factors.
已经提出了几种用于检测亚临床动脉粥样硬化及其进展的标志物。我们旨在分析经典危险因素对非糖尿病一级预防队列中亚临床颈动脉粥样硬化的存在和短期进展的影响。
该分析纳入了在基线和5年随访时完成访视的参与者(N = 141;女性56.7%,男性43.3%;年龄49.6±4.7岁)。分析了临床和实验室参数、风险概况、颈动脉内膜中层厚度(CIMT)和斑块存在情况。
与基线相比,随访结束时平均CIMT(从0.54±0.09毫米增加到0.62±0.10毫米;P<0.001)、颈动脉斑块患病率(从4.8%增加到17.9%;P<0.001)以及年龄和性别调整后的异常CIMT(从52.9%增加到78.8%;P<0.001)均有显著进展。在多变量回归分析中,在经典危险因素中,只有危险因素的数量、代谢综合征和SCORE(系统性冠状动脉风险评估)风险中的危险因素数量对颈动脉斑块的发生(Exp(B)=1.71;P = 0.017)和5年CIMT进展显示出独立且显著的影响。
在短期随访期间,证实了亚临床动脉粥样硬化有显著进展。危险因素的数量可预测颈动脉斑块的发生和CIMT进展。亚临床颈动脉粥样硬化的高患病率和短期进展是对50岁以上无症状中年受试者进行个性化心血管风险分层筛查的依据,这些受试者心血管风险为低至中度,尤其是有多种危险因素时。